- Report
- November 2020
- 111 Pages
Brazil
From €3880EUR$3,995USD£3,347GBP
- Report
- November 2020
- 111 Pages
Japan
From €3880EUR$3,995USD£3,347GBP
- Report
- November 2020
- 110 Pages
China
From €3880EUR$3,995USD£3,347GBP
- Report
- November 2020
- 111 Pages
South Korea
From €3880EUR$3,995USD£3,347GBP
- Report
- November 2020
- 111 Pages
Russia
From €3880EUR$3,995USD£3,347GBP
- Report
- November 2020
- 112 Pages
Spain
From €3880EUR$3,995USD£3,347GBP
- Report
- November 2020
- 112 Pages
Italy
From €3880EUR$3,995USD£3,347GBP
- Report
- November 2020
- 112 Pages
France
From €3880EUR$3,995USD£3,347GBP
- Report
- November 2020
- 112 Pages
United Kingdom
From €3880EUR$3,995USD£3,347GBP
- Report
- November 2020
- 110 Pages
Mexico
From €3880EUR$3,995USD£3,347GBP
The Prosthetic Heart Valve Procedure market is a subset of the larger Surgical Procedures market. It involves the replacement of a patient's diseased or damaged heart valve with a prosthetic valve. This procedure is typically performed by a cardiothoracic surgeon, and is done to improve the patient's quality of life and reduce the risk of further complications. The procedure is typically done through open-heart surgery, but can also be done through minimally invasive techniques.
The Prosthetic Heart Valve Procedure market is highly competitive, with a number of companies offering a variety of products and services. Some of the major players in the market include Edwards Lifesciences, Medtronic, St. Jude Medical, Boston Scientific, and Sorin Group. These companies offer a range of products, including mechanical and tissue valves, as well as a variety of accessories and services. Show Less Read more